# Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations

Study · id `cardio:ct-nct05058482` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05058482](<https://clinicaltrials.gov/study/NCT05058482>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05058482

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 116 participants.

## Technical summary

Registry record NCT05058482. Randomized; single masking; primary purpose treatment. Start 2021-12-02 (actual); primary completion 2023-10-17 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 116 participants (planned count; ClinicalTrials.gov record NCT05058482, source copy `cardio:ctgov-nct05058482-2022-05-06`, retrieved 2026-11-18)
- Started: 2021-12-02 (actual) (ClinicalTrials.gov record NCT05058482, source copy `cardio:ctgov-nct05058482-2022-05-06`, retrieved 2026-11-18)
- Primary completion: 2023-10-17 (anticipated) (ClinicalTrials.gov record NCT05058482, source copy `cardio:ctgov-nct05058482-2022-05-06`, retrieved 2026-11-18)
- Completion: 2024-10-17 (anticipated) (ClinicalTrials.gov record NCT05058482, source copy `cardio:ctgov-nct05058482-2022-05-06`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT05058482, source copy `cardio:ctgov-nct05058482-2022-05-06`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05058482-2022-05-06`, retrieved 2026-11-18)

## The registry's words

- Brief title: Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations
- Condition: Intracranial Arteriovenous Malformations
- Intervention (Device): embolism
- Lead sponsor: Suzhou Hengruihongyuan Medical Technology Co. LTD
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arteriovenous malformation (AVM) (`cardio:arteriovenous-malformation`)

## Provenance

Content hash: 66d73e0c74f492edd318352efc77de04843bf41c83c4b6ee80c90259049ebb8b
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
